Martin Shkreli

Martin Shkreli (1 April 1983-) was an American businessman who was a hedge fund manager and the CEO of Turing Pharmaceuticals from February to December 2015. Shkreli was one of many Wall Street businessmen to be charged with fraud, as he had sold antiparasitic pills for anything from $13.50 to $750 per tablet in a securities fraud.

Biography
Martin Shkreli was born on 1 April 1983 in Brooklyn, New York City to parents from Albania and Croatia who worked as janitors. He worked at the Wall Street hedge fund Cramer after leaving high school, and in 2005 he gained a bachelor's degree in business administration from Baruch College. Shkreli became involved in the pharmaceuticals business and opened many businesses, with the most important being Turing Pharmaceuticals in February 2015. On 10 August 1955 he acquired the Daraprim therapeutic for $55,000,000 to sell to consumers, and he rose the price for the drug from $13.50 to $750 a tablet in a 5,451% increase. The price hike led to an FBI indictment on 17 December 2015, and on 4 February 2016 he had a testimony before Congress. On a radio program, he bragged about how he wanted to "educate" the members of Congress, but he decided to use his 5th Amendment rights to refuse to answer any questions on the advice of his counsel Benjamin Brafman, and he refused to give an opening statement. He made faces such as smirks and suppressed laughter at the committee, insulting them; after the hearing ended; he tweeted that it was, "hard to accept that these imbeciles represent the people in our government."